Polymerase Chain Reaction (PCR) In Medical Application - An Analytical Report, 2009-2015

Polymerase Chain Reaction (PCR) In Medical Application - An Analytical Report, 2009-2015

Global Market Watch:
The global PCR market is projected to reach around US$27.4 billion by 2015, with a Compounded Annual Growth Rate (CAGR) of 13.9% for the analysis period, 2009-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$10.7 billion by end-2010. Europe and Asia-Pacific together account for more than 50% of the global market share. Interestingly, Latin America is seen as the fastest growing market with a CAGR of 14.8%, to worth around US$1.3 billion in 2015.

Among the techniques used, Q-PCR appears to be the fastest growing market with a CAGR of 14.9%. Reverse-Transcription PCR (RT-PCR) and Assembly PCR are expected grow with a CAGR of 14.3% and 14% respectively.

Based on the classification by products/tools, PCR Reagents are expected to be fastest growing market with a CAGR of 14.6%. PCR Consumables and PCR Machines are expected grow with a CAGR of 14.2% and 13.1% respectively.

Global PCR Research market forecasts a CAGR of 13.3% during the analysis period 2009-2015. PCR Diagnosis market is expected to represent the market share of 29.9% by 2015. PCR Infectious Diseases stand as the fastest growing market.

Report Focus:
The report “Polymerase Chain Reaction (PCR) In Medical Application - An Analytical Report, 2009-2015” reviews the latest PCR market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.
The report primarily focuses on:
• Emerging market trends
• Advancements in the technological space
• Market demand of the segments (by-region)
• Key growth areas and market size
• Key competitor’s Edge

The analysis primarily deals with three major PCR techniques, product/tools and end-users application market.
Further, the subdivided categories include:
PCR Techniques
• Q-PCR
• Reverse-Transcription PCR (RT-PCR)
• Assembly PCR
• Inverse PCR
• Other (Multiplex, Nested, Hot Start and Others)

PCR Product/Tools
• PCR Machines
• PCR Reagents
• PCR Consumables
• Other (Software, Pipetting Robot & etc.,)

PCR End-Users Application
• Research
- DNA Sequencing
- DNA Cloning
- Gene Expression
- Other
• Diagnosis
- Cancer
- Tissue Typing
- Genetic Abnormalities
- Other
• Infectious Diseases
• Forensic Sciences &
• Other

The period considered for the PCR market analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (France, Germany, United Kingdom, Italy, Spain and Rest of Europe), Asia- Pacific (Japan, China, India, Korea and Rest of Asia-Pacific), Latin America (Brazil, Columbia, Argentina and Rest of Latin America) and Rest of the World. Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 850 leading market players are identified and 49 key companies that project improved market activities in the near future are profiled. The report consists of 379 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

The broad ‘life science’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the PCR industry, even during the recession years, confirms the positive growth prospects going ahead. Among the major developments in the recent years, gene amplification technology indicates the highest potential growth. Molecular diagnostics and the Human Genome Project (HGP) are two of the main drivers that contribute to the growth of gene amplification technology. It covers all segments such as drug discovery, DNA amplification, forensic identification, gene therapy and diagnosis. Freshly developed PCR Instruments for detecting most of the life threatening diseases also signal positive demand growth. Among the PCR types, q-PCR is expected witness the largest CAGR during 2009-2015.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the PCR industry.
TABLE OF CONTENTS

I. REPORT FOCUS
PCR TECHNIQUE'S
PRODUCT/TOOLS IN PCR
PCR APPLICATION

A. INTRODUCTION

DEFINING POLYMERASE CHAIN REACTION
SCOPE OF POLYMERASE CHAIN REACTION
HISTORY OF POLYMERASE CHAIN REACTION
VARIATIONS OF POLYMERASE CHAIN REACTION
ALLELE-PRECISE PCR
PCA (POLYMERASE CYCLING ASSEMBLY) OR ASSEMBLY PCR
ASYMMETRIC PCR
HELICASE-RELIANT AMPLIFICATION
HOT-START PCR
INTERSEQUENCE-SPECIFIC PCR
REVERSE PCR
LIGATION MEDIATED PCR
METHYLATION SPECIFIC PCR
MINIPRIMER PCR
MULTIPLEX LIGATION-RELIANT PROBE AMPLIFICATION
MULTIPLEX PCR
NESTED PCR
OVERLAP-EXTENSION PCR
QUANTITATIVE PCR
RT-PCR
SOLID-PHASE PCR
TAIL-PCR
TOUCHDOWN PCR
PAN-AC
UNIVERSAL FAST WALKING

MERITS & DEMERITS OF POLYMERASE CHAIN REACTION
OPTIMIZING POLYMERASE CHAIN REACTION
THERMAL CYCLERS (POLYMERASE CHAIN REACTION)
PHASES OF POLYMERASE CHAIN REACTION
PARAMETERS FOR SUCCESSFUL PCR
I) METAL ION COFACTORS AND PCR
II) SUBSTRATES AND SUBSTRATE ANALOGS FOR PCR
III) BUFFERS AND SALTS FOR PCR
IV) COSOLVENTS

THERMAL CYCLING CONSIDERATIONS
I) PCR VESSELS
II) TEMPERATURE AND CYCLE TIME OPTIMIZATION
III) PCR AMPLIFICATION CYCLE NUMBER
IV) ENZYME / TARGET
V) HOT START CONDITIONS

THEORY AND METHODOLOGY OF POLYMERASE CHAIN REACTION
METHODOLOGY OF USE

PCR - IMPROVISED TECHNIQUE FOR TESTING NUCLEIC ACIDS
FINAL ELONGATION
POLYMERASE CHAIN REACTION IN CLINICAL DETECTIONS

B. TECHNIQUE'S OF POLYMERASE CHAIN REACTION (PCR)
REAL-TIME PCR
ADVANTAGES OF REAL-TIME PCR
HISTORY OF REAL-TIME PCR

REVERSE -TRANSCRIPTION PCR

ASSEMBLY PCR
ASSEMBLY PCR OLIGO MAKER

INVERSE PCR

OTHER
MULTIPLEX PCR
NESTED PCR
HOT-START PCR

POLYMERASE CHAIN REACTION (PCR) - TECHNIQUE'S - GEOGRAPHY MARKET BRIEFING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

C. PRODUCT/TOOLS IN POLYMERASE CHAIN REACTION (PCR)
PCR MACHINES
REAL-TIME PCR MACHINES
REAL-TIME PCR INSTRUMENTATION

PCR REAGENTS
ROLE OF PCR REAGENTS
GOTAQ PCR MIX
PRIMERS
NEXT GENERATION PCR REAGENTS FOR CLINICAL DIAGNOSTICS
PCR REAGENT MARKET TRENDS
DNA TEMPLATE

PCR CONSUMABLES

OTHER
PCR SOFTWARE
PCR ROBOTICS
THE AUTOMATION AND USAGE OF ROBOTICS IN AMPLIFICATION ASSAYS
PRE-PCR ROBOTIC SYSTEM
THE POST-PCR ROBOTIC SYSTEM
INTEGRATED ROBOTIC SYSTEM FOR HIGH SAMPLE THROUGHPUT WITHIN A DNA DATABASING UNIT

PCR ARRAYS
NEED OF PCR ARRAYS
DOCTRINE OF ASSAY CORROBORATION FOR NUCLEIC ACID DIAGNOSTIC TESTS

ASSAY CORROBORATION - AN INTRODUCTION
SELECTING AN ASSAY FITTING ITS INTENDED PURPOSE

CONSIDERATIONS TOWARDS PRIMITIVE ASSAY DEVELOPMENTS
A) CARE AND RESTRAINTS
B) PROTECTIONS FOR AVOIDING FALSE-POSITIVE RESULTS
C) SAFEGUARDS FOR AVOIDING NEGATIVE OUTCOMES
D) STANDARDS' PREPARATION

ASSAY CORROBORATION - PART I
1. REAGENTS' OPTIMIZATION BESIDES STANDARDIZATION AND ASCERTAINING
CRUCIAL CHECKING PARAMETERS
2. REPRODUCIBILITY
3. DIAGNOSTIC PARTICULARITY AND SENSITIVITY DETERMINATION

ASSAY CORROBORATION - PART 2
1. ASSAY CONDUCT'S PERFORMANCE DETERMINATION
A) ANIMAL POPULATION'S REFERENCE
I) REFERENCE ANIMALS' NEGATIVITY
II) REFERENCE ANIMALS' POSITIVITY
III) OTHER ASSAYS' DETERMINATION OF STATUS OF REFERENCE ANIMALS
2. ENTRY-LEVEL DETERMINATION

ASSAY CORROBORATION - PART 3
1. STARTING ASSAY REPRODUCIBILITY

ASSAY CORROBORATION - PART 4
1. CURRICULUM ACCOMPLISHMENT
2. OBSERVING ASSAY FUNCTIONING'S VALIDITY
A) EXPLANATION OF ANALYSES' RESULTS - ISSUES UPSETTING ASSAY VALIDITY
B) MAINTAINING CORROBORATION CRITERIA

POLYMERASE CHAIN REACTION (PCR) - PRODUCT/TOOLS - GEOGRAPHY MARKET BRIEFING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

D. POLYMERASE CHAIN REACTION (PCR) BASED ON APPLICATION
HUMAN GENOME PROJECT
HUMAN HEALTH
GENOME SEQUENCED IN THE PUBLIC (HGP) AND PRIVATE PROJECTS
CELERA GENOMICS PRIVATE-SECTOR PROJECT
FUNDING FOR HUMAN GENOME PROJECT RESEARCH
GENOMIC DNA ISOLATION
DNA MAGNIFICATION AND QUANTIFICATION

APPLYING PCR TECHNIQUES IN USUAL MOLECULAR DIAGNOSTICS
1) THE DOCTRINE OF PCR
DNA MAGNIFICATION
RNA MAGNIFICATION (ANNULLED PCR TRANSCRIPT)
DETECTING PCR AMPLICON
2) TRADITIONAL PCR
3) CUDDLED PCR
4) CONCURRENT PCR
5) COMPLEX PCR

ADVANCES IN MOLECULAR DIAGNOSIS
PCR IN RESEARCH APPLICATION
DNA SEQUENCING
MAXAM-GILBERT SEQUENCING
CHAIN TERMINATOR SEQUENCE
DYE-TERMINATOR SEQUENCE

INSTRUMENTS USED IN DNA SEQUENCING
LARGE-SCALE SEQUENCING

LATEST TECHNIQUES FOR SEQUENCING
IN-VITRO CLONAL AMPLIFICATION
BRIDGE PCR METHOD
HIGH-THROUGHPUT SEQUENCING
SEQUENCING BY LIGATION
PARALLELIZED SEQUENCING
HYBRIDIZATION

MAJOR LANDMARKS IN DNA SEQUENCING
DNA SEQUENCES OF THE FUTURE
DRAFT SEQUENCE AND FINISHED SEQUENCE

DNA CLONING
PCR AND MOLECULAR CLONING
THE BIOMARKER WITH PCR TECHNOLOGY
NEED OF CUSTOM PCR ARRAYS FOR BIOMARKER DISCOVERY AND VALIDATION

OTHER
GENOTYPING

PCR IN DISEASES' DIAGNOSIS APPLICATION
APPLICATION AND ACCEPTANCE OF PCR TO DIAGNOSE DISEASES
SCOPE
INTERFERENCE
ELISA PROCEDURES
DNA FINGERMARKINGS VIS-À-VIS BREAST CANCER

DISEASE DIAGNOSIS WITH POLYMERASE CHAIN REACTION (PCR) APPLICATION
CATEGORIZATION
CONVEYANCE
ARRESTING CONVEYANCE
IDENTIFICATION AND MEDICAL AID
DIAGNOSES' PROCEDURES
MICROBE'S CULTURE
RESEARCH
BIOCHEMICAL ANALYSIS
DIAGNOSING MOLECULES

CANCER
LATE POLYMERASE CHAIN REACTION (PCR) APPLICATION - CANCER DETECTION GENOME
INTRODUCTION
HISTORY & IMPORTANCE
STRATAGEM FOR INITIAL CANCER DISCOVERY
LOGIC BEHIND LATE-PCR RESULTANT TESTS
CONCLUSION

GENETIC ABNORMALITIES
PCR IN GENETIC ABNORMALITIES
GENETIC DIAGNOSIS BY USING POLYMERASE CHAIN REACTION (PCR)

TISSUE TYPING

OTHER
INFECTIOUS DISEASE
HIV
TUBERCULOSIS
TESTS

POLYMERASE CHAIN REACTION (PCR) IN FORENSIC SCIENCE
DNA TYPING
DNA PROFILING
THE PROCESS OF DNA PROFILING
PCR ANALYSIS
RFLP ANALYSIS
STR ANALYSIS

DNA FINGERPRINT
DISTINCTIVE CHARACTERISTICS OF DNA FINGER PRINT
DNA STRUCTURE
DNA FINGER PRINTING PROCEDURE
(A) SEGREGATION OF DNA
(B) CUTTING, SEPARATING AND SIZING
(C) SHIFTING TO A NYLON SHEET
(D) PROBE
(E) DNA FINGERPRINT
DNA FINGERPRINTS USES

INVESTIGATION AND EVIDENCE COLLECTION
IDENTIFICATION OF PATERNITY
DIAGNOSIS AND CURE FOR DIFFERENT GENETIC DISORDERS
IDENTIFICATION OF THE INDIVIDUAL

FORENSIC MEDICINE
ROLE OF MOLECULAR DIAGNOSTICS IN FORENSIC SCIENCES
AUTOMATED MOLECULAR DIAGNOSTICS
PCR MAGNIFICATION AND FINGERMARKING
THE PAST OF FORENSIC SCIENCE
BRANCHES OF FORENSIC SCIENCE
REFUTABLE FORENSIC TECHNIQUES
LAWSUIT SCIENCE
FORENSIC SCIENCE IN FABLES
PCR TECHNOLOGY METHOD TO FORENSIC SCIENCE
DO-IT-YOURSELF KIT VERSUS KIT TECHNOLOGY
LABORATORY PARAMETERS AND PRECAUTIONS
MERITS OF PCR ENGINEERING
DEMERITS OF PCR ENGINEERING
PCR ENGINEERING'S COST CONSIDERATIONS

OTHER APPLICATION
PRIMITIVE DNA AND DEVELOPMENTAL ASSOCIATIONS
PALEONTOLOGISTS
PCR IN FOOD MICROBIOLOGY
GENETICALLY MODIFIED ORGANISM (GMO) DETECTION
CONTEMPORARY SYSTEMS, BIOLOGICAL STUDIES AND ANIMALS' CONDUCTS

FUTURE OF POLYMERASE CHAIN REACTION (PCR)
HOME BREW
IN-HOUSE (HOME-BREW) PCR METHODS
HOME-BREW ASSAYS, INCLUDING REAL-TIME PCR

POLYMERASE CHAIN REACTION (PCR) - END-USERS APPLICATION - GEOGRAPHY MARKET BRIEFING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

POLYMERASE CHAIN REACTION (PCR) - BY END-USERS APPLICATION - RESEARCH APPLICATION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

POLYMERASE CHAIN REACTION (PCR) - BY END-USERS APPLICATION - DIAGNOSIS APPLICATION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

II. MARKET ANALYSIS
POLYMERASE CHAIN REACTION (PCR) IN MEDICAL APPLICATION - INDUSTRY SNAPSHOT

A. POLYMERASE CHAIN REACTION (PCR) IN MEDICAL APPLICATION - SEGMENTATION

POLYMERASE CHAIN REACTION (PCR) - GLOBAL
POLYMERASE CHAIN REACTION (PCR) - GEOGRAPHIC REGION

POLYMERASE CHAIN REACTION (PCR) - BY COUNTRY ANALYSIS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA

POLYMERASE CHAIN REACTION - BY TECHNIQUE - GLOBAL
POLYMERASE CHAIN REACTION (PCR) - TECHNIQUE - GEOGRAPHIC REGION

Q-PCR
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

REVERSE-TRANSCRIPTION (RT) PCR
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

ASSEMBLY PCR
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

INVERSE PCR
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

OTHER PCR TECHNIQUE
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

POLYMERASE CHAIN REACTION (PCR) - BY PRODUCTS/TOOLS
POLYMERASECHAINREACTION (PCR) - PRODUCTS/TOOLS - GEOGRAPHICREGION

PCR MACHINES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

PCR REAGENTS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

PCR CONSUMABLES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

OTHER PCR PRODUCTS/TOOLS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

POLYMERASE CHAIN REACTION (PCR) - END-USERS APPLICATION
POLYMERASE CHAIN REACTION (PCR) - APPLICATION - GEOGRAPHIC REGION

PCR RESEARCH
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

POLYMERASE CHAIN REACTION (PCR) - END-USERS APPLICATION - RESEARCH - BY TYPE
POLYMERASE CHAIN REACTION (PCR) - APPLICATION - RESEARCH - BY TYPE- GEOGRAPHIC REGION

DNA SEQUENCING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

DNA CLONING
NORTH AMERICA
EUROPE
LATIN AMERICA
REST OF WORLD

GENE EXPRESSION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

OTHER RESEARCH APPLICATION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

PCR DIAGNOSIS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

POLYMERASE CHAIN REACTION (PCR) - APPLICATION - DIAGNOSIS - BY TYPE
POLYMERASE CHAIN REACTION (PCR) - APPLICATION - DIAGNOSIS- BY TYPE- GEOGRAPHIC REGION

CANCER
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

GENETIC ABNORMALITIES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

TISSUE TYPING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

OTHER DIAGNOSIS APPLICATION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

POLYMERASE CHAIN REACTION (PCR) - INFECTIOUS DISEASES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

POLYMERASE CHAIN REACTION (PCR) - FORENSIC SCIENCES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

POLYMERASE CHAIN REACTION (PCR) - OTHER APPLICATION
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD

B. GROWTH RATE ANALYSIS
GLOBAL POLYMERASE CHAIN REACTION (PCR) - MARKET GROWTH RATES

POLYMERASE CHAIN REACTION (PCR) MARKET - TECHNIQUE
GLOBAL PCR TECHNIQUE - GROWTH RATES

Q-PCR
MARKET GROWTH RATES FOR PCR TECHNIQUE - Q-PCR

REVERSE-TRANSCRIPTION PCR (RT-PCR)
MARKET GROWTH RATES FOR PCR TECHNIQUE - REVERSE-TRANSCRIPTION PCR (RT-PCR)

ASSEMBLY PCR
MARKET GROWTH RATES FOR PCR TECHNIQUE - ASSEMBLY PCR

INVERSE PCR
MARKET GROWTH RATES FOR PCR TECHNIQUE - INVERSE PCR

POLYMERASE CHAIN REACTION (PCR) MARKET - PRODUCTS/TOOLS
GLOBAL PCR PRODUCTS/TOOLS - GROWTH RATES

PCR MACHINES
MARKET GROWTH RATES FOR PCR PRODUCTS/TOOLS - PCR MACHINES

PCR REAGENTS
MARKET GROWTH RATES FOR PCR PRODUCTS/TOOLS - PCR REAGENTS

PCR CONSUMABLES
MARKET GROWTH RATES FOR PCR PRODUCTS/TOOLS - PCR CONSUMABLES

POLYMERASE CHAIN REACTION (PCR) MARKET - END-USER APPLICATION
GLOBAL PCR END-USER APPLICATION - GROWTH RATES

PCR RESEARCH
MARKET GROWTH RATES FOR PCR END-USER APPLICATION - PCR RESEARCH

POLYMERASE CHAIN REACTION (PCR) MARKET - RESEARCH - APPLICATION
GLOBAL PCR RESEARCH APPLICATION - GROWTH RATES

DNA SEQUENCING
MARKET GROWTH RATES FOR PCR RESEARCH APPLICATION - DNA SEQUENCING

DNA CLONING
MARKET GROWTH RATES FOR PCR RESEARCH APPLICATION - DNA CLONING

GENE EXPRESSION
MARKET GROWTH RATES FOR PCR RESEARCH APPLICATION - GENE EXPRESSION

PCR DIAGNOSIS
MARKET GROWTH RATES FOR PCR END-USER APPLICATION - PCR DIAGNOSIS

POLYMERASE CHAIN REACTION (PCR) MARKET - DIAGNOSIS - APPLICATION
GLOBAL PCR DIAGNOSIS APPLICATION - GROWTH RATES

CANCER
MARKET GROWTH RATES FOR PCR DIAGNOSIS APPLICATION - CANCER

TISSUE TYPING
MARKET GROWTH RATES FOR PCR DIAGNOSIS APPLICATION - TISSUE TYPING

GENETIC ABNORMALITIES
MARKET GROWTH RATES FOR PCR DIAGNOSIS APPLICATION - GENETIC ABNORMALITIES

INFECTIOUS DISEASES
MARKET GROWTH RATES FOR PCR END-USER APPLICATION - INFECTIOUS DISEASES

FORENSIC SCIENCES
MARKET GROWTH RATES FOR PCR END-USER APPLICATION - FORENSIC SCIENCES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW
A. INDUSTRY ACTIVITIES
MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/INNOVATIONS/PRODUCT LAUNCHES/ETC……
THERMO FISHER SCIENTIFIC TO ACQUIRE LIFE TECHNOLOGIES CORPORATION
VEREDUS LABORATORIES APPROVES THE CURRENT VERSION OF VEREFLU
BGI-SHENZHEN ACQUIRES COMPLETE GENOMICS INC.
INIBSA GROUP ACQUIRES BIOTECH BIOTOOLS.
AFFYMETRIX AND DNA LINK SIGN PARTNERSHIP FOR PBA PROGRAM FOR HUMAN IDENTIFICATION
MAST UNVEILS NEW ISOTHERMAL NUCLEIC ACID AMPLIFICATION KITS.
FULL SERVICE OF MICROBIAL DIVERSITY PROFILING IS NOW AVAILABLE.
BIOSEARCH TECHNOLOGIES ANNOUNCES ACQUISITION OF DIVISIONS OF DNA TECHNOLOGY AND VITRABIO.
COUNT YOUR DNA WITH DIGITAL PCR AT TATAA BIOCENTER.
MOBIDIAG'S PROVE-IT BONE&JOINT, A HIGH-QUALITY MULTIPLEXED MOLECULAR DIAGNOSTIC TECHNOLOGY FOR INFECTIOUS DISEASES, ACHIEVES CE-IVD MARKING.
SPOTSTUDIO‘S EARLY ACCESS PROGRAM STARTED.
FULL PD+ SEQUENCING SERVICE IN TUBE FORMATS IS NOW AVAILABLE.
THERMO FISHER SCIENTIFIC LAUNCHES SURETECT PCR SYSTEM FOR FOOD PATHOGEN DETECTION
CELL SIGNALING TECHNOLOGY RECEIVES PATENT FOR PCR METHODS FOR DETECTION OF A SUBSET OF TREATABLE NON-SMALL CELL LUNG CANCERS
BIO-RAD ACQUIRES ABD SEROTEC
THERMO FISHER SCIENTIFIC SHOWCASES INTEGRATED LAB AUTOMATION PORTFOLIO AT SLAS 2013
ILLUMINA ROLLS OUT SEQUENCING TECHNOLOGY INNOVATIONS
TATAA BIOCENTER INTRODUCES QPCR WORKFLOW
TTP LABTECH SHOWCASES ADVANCES IN ASSAY MINIATURIZATION WITH MOSQUITO AT SLAS 2013.
'FAST PCR' WITH THE PEQSTAR 2X NOW A REALITY.
AMGEN TO ACQUIRE DECODE GENETICS.
LABOR DIAGNOSTIK LEIPZIG AND QIAGEN JOIN FORCES TO OFFER SOLUTIONS FOR VETERINARY TESTING PORTFOLIO.
SCIENION AND GENOMICA EXPAND COLLABORATION TO PROVIDE A NEW PRINTING TECHNOLOGY FOR MULTIPLE APPLICATIONS.
GENEDATA ANNOUNCED PARTNERSHIP WITH LIFE TECHNOLOGIES CORPORATION.
OCIMUM BIOSOLUTIONS OBTAINS DISTRIBUTION PARTNER FOR SPOLIGOTYPING KITS IN EUROPE.
RAINDANCE TECHNOLOGIES AND INTEGRATED DNA TECHNOLOGIES COLLABORATE TO DEVELOP REAGENTS AND CONSUMABLES FOR DIGITAL PCR
PROMEGA LAUNCHES NEW GOTAQ REAL-TIME PCR SYSTEMS FOR PROBE-BASED DETECTION
TRANSGENOMIC AND NYU COLLABORATE FOR LUNG CANCER STUDY USING ICE COLD-PCR
THERMO FISHER SCIENTIFIC INAUGURATES MOLECULAR BIOLOGY CENTER OF EXCELLENCE IN LITHUANIA
ABBOTT COLLABORATE WITH ASTELLAS PHARMA FOR PHASE 3 CLINICAL TRIAL IN CMV VACCINE.
IDAHO TECHNOLOGY, INC. RENAMED BIOFIRE DIAGNOSTICS, INC. (TM)
SIGMA LIFE SCIENCE ADDS KICQSTART PRIMERS TO ITS QPCR PORTFOLIO
QUINTILES ACQUIRES EXPRESSION ANALYSIS
NEW PRODUCT UPDATE IN AUGUST: THE QPCRSOFT SOFTWARE INCLUDES EVALUATION MODULE “GENOTYPING”.
ADIAGENE ANNOUNCES NEW ADIAVET BESNOITIA REAL TIME PCR KIT.
TAKEDA EXPANDED ITS COLLABORATION WITH GENEDATA.
SOL GROUP ACQUIRES MAJORITY STAKE IN DIATHEVA TO MARK ANOTHER STEP FORWARD IN THE BIOTECH SECTOR.
SACACE BIOTECHNOLOGIES INTRODUCES SACYCLER-96, A NEW REAL TIME PCR SYSTEM.
BECKMAN COULTER, INC. RECEIVES CLIA CERTIFICATE AND MASSACHUSETTS STATE LICENSURE FOR CLINICAL SEQUENCING
INTUITIVE BIOSCIENCES SIGNS AGREEMENT TO ACQUIRE CERTAIN ASSETS OF GENTEL BIOSCIENCES
AFFYMETRIX AND SCREENCELL SIGN AGREEMENT FOR WORLDWIDE DISTRIBUTION OF CTC TECHNOLOGY
VANDALIA RESEARCH RECEIVES U.S. PATENT PROTECTION FOR LARGE-SCALE DNA PRODUCTION TECHNOLOGY
MICROSYNTH AG ANNOUNCES TWO SERVICE IMPROVEMENTS IN THE FIELD OF DNA SANGER SEQUENCING.
INTEGROMICS LAUNCHES OMICSOFFICE, A TOOL THAT FEATURES FUNCTIONAL AND COMPARATIVE APPLICATIONS OFFERING NEW BIOLOGICAL INSIGHTS.
ANALYTIK JENA TO SHOWCASE TECHNOLOGY TRENDS IN THE FIELD OF ANALYTICAL INSTRUMENTATION AND BIOTECHNOLOGY.
INGENUITY SYSTEMS AND LIFE TECHNOLOGIES LAUNCH INGENUITY IREPORT FOR REAL-TIME PCR
QUEST DIAGNOSTICS RECEIVES FDA CLEARANCE FOR SIMPLEXA C. DIFFICILE MOLECULAR TEST
INGENUITY SYSTEMS AND LIFE TECHNOLOGIES LAUNCH INGENUITY IREPORT FOR REAL-TIME PCR
HCV GENOTYPE PLUS REAL-TM, A NEW REAL TIME PCR TEST TO DETERMINE HCV-RNA GENOTYPES.
THERMO FISHER SCIENTIFIC DISPLAYS NEW REAL-TIME PCR SYSTEM
THERMO FISHER SCIENTIFIC RELEASES NEW PERSONAL NANODROP UV-VIS SPECTROPHOTOMETER
ABBOTT TO COLLABORATE WITH GENLAB FOR RAPID MOLECULAR DIAGNOSIS OF SERIOUS ORTHOPEDIC INFECTIONS
CHUGAI PHARMACEUTICAL EXTENDED MULTI-YEAR LICENSING AGREEMENT WITH GENEDATA.
LIFE TECHNOLOGIES INTRODUCES ION AMPLISEQ CUSTOM PANELS FOR UNLOCKING INNUMERABLE DISEASE-RELATED RESEARCH SAMPLES FOR ANALYSIS
ADIAGENE'S PCR DETECTION KIT FOR THE NEWLY IDENTIFIED SCHMALLENBERG VIRUS OBTAINS ANSES VALIDATION.
BECKMAN COULTER TO LAUNCH SPRIWORKS HT, AN AUTOMATIC SAMPLE PREPARATION SYSTEM FOR NEXT-GENERATION SEQUENCING, AT SLAS2012
ABBOTT SIGNS AGREEMENT WITH UNIVERSITY OF NORTH TEXAS SCIENCE CENTER FOR PLEX-ID EVALUATION
LONGGENE ROLLS OUT A300 FAST THERMAL CYCLER
QIAGEN JOINS AMDEC'S VENDOR PARTNERSHIP PROGRAM
BORDETELLA REAL-TM: A REAL TIME PCR KIT FOR DETECTION OF THE BORDETELLA FAMILY OF DISEASES.
EUROPEAN COMMISSION TIGHTENS MEASURES FOR THE IMPORT OF GM RICE FROM CHINA.
IDT LAUNCHES GENOME-WIDE QPCR PRIMERS FOR USE WITH INTERCALATING DYES
XENETIC BIOSCIENCES PLC ANNOUNCES ACQUISITION OF SYMBIOTEC GMBH AND COMPLETION OF ARRANGEMENTS WITH SERUM INSTITUTE OF INDIA.
QUEST DIAGNOSTICS INTRODUCES SIMPLEXA DENGUE TEST IN BRAZIL
IDT EXPANDS ZEN PROBES PORTFOLIO FOR QPCR
PERKINELMER ACQUIRED CALIPER LIFE SCIENCES
TRINEAN AND TATAA BIOCENTER COMMENCE COLLABORATION.
ABBOTT EXPANDS AGREEMENT WITH GSK TO INCLUDE DEVELOPMENT OF A COMPANION DIAGNOSTIC TEST.
SIGMA LIFE SCIENCE UPGRADES OLIGOARCHITECT ONLINE QPCR TOOL
GREINER BIO-ONE'S WHITE PCR MICROPLATES IMPROVE REAL TIME PCR SENSITIVITY.
SENTINELGX PHARMACOGENOMIC AND COMPANION DIAGNOSTIC BLOODRNA SERVICE IS NOW AVAILABLE.
ANALYSIS OF THE USE OF HIGH YIELD BUFFER TO ENHANCE PCRS.
SONY PURCHASES MICRONICS, INC.
GENEWORKS CHAINS THE HUMAN MITOCHONDRIAL TRANSCRIPTOME
EPPENDORF GETS LICENSES TECHNOLOGY FOR THERMAL CYCLERS TO BULLDOG BIO
CALIPER LAUNCHES ZEPHYR NGS POST-PCR WORKSTATION
HKSH SELECTS GE HEALTHCARE'S PET/CT+MR FOR MANAGEMENT OF DISEASES
ABBOTT INTRODUCES ALK GENETIC TEST FOR NSCLC
QIAGEN ACQUIRES CELLESTIS
ABBOTT OBTAINS FDA APPROVAL FOR ALK GENE TEST
BIONEER RELEASES H1N1 VIRUS DIAGNOSTIC KIT
COMPLETE GENOMICS TO SEQUENCE DNA FOR NCI'S PEDIATRIC CANCER STUDY
ABBOTT GETS FDA CLEARANCE FOR VYSIS CLL FISH PROBE KIT
ABBOTT ANNOUNCES SUCCESSFUL TREATMENT OF THE FIRST PATIENT IN JAPAN WITH ABSORB BIORESORBABLE VASCULAR SCAFFOLD
QIAGEN AND PFIZER ANNOUNCE PARTNERSHIP
ABBOTT GETS FDA APPROVAL FOR RX HERCULINK ELITE RENAL STENT SYSTEM
ABBOTT INTRODUCES PLEX-ID VECTOR-BORNE TEST
BIOGEN IDEC AND ABBOTT ANNOUNCE SUCCESS OF SELECT TRIAL FOR RRMS
QIAGEN INAUGURATES TAIWAN SUBSIDIARY IN TAIPEI
QIAGEN COMPLETES SECOND U.S. SUBMISSION FOR THERASCREEN KRAS RGQ PCR KIT
ILLUMINA AND THE UNIVERSITY OF OXFORD COLLABORATE FOR PERSONALIZED MEDICINE
GENOVAC RENAMED ALDEVRON FREIBURG
BD SIGNS AGREEMENT TO ACQUIRE CARMEL PHARMA
STARTING UP THE GENE THERAPY PROJECT IN CHINA
PROMEGAPOWERPLEX 18D SYSTEM OBTAINS NDIS APPROVAL FOR OFFENDER DNA PROFILING
AFFYMETRIX STARTS SHIPMENT OF GENE PROFILING REAGENTS
LIFE TECHNOLOGIES INTRODUCES APPLIED BIOSYSTEMSVETMAXTM-GOLD SIV DETECTION KIT
BIOTAGE INTRODUCES MICROWAVE PEPTIDE SYNTHESIZER
RAISING THE BAR IN MICROWAVE SYNTHESIS BY BIOTAGE
GRIFOLS COMPLETES ACQUISITION OF TALECRIS AND ANNOUNCES LISTING OF ITS ADSS ON NASDAQ
COMPLETE GENOMICS INTRODUCES CANCER GRANT PROGRAM
PROMEGA INTRODUCES BIOLUMINESCENT HDAC ASSAYS
QIAGEN PREPARES PROPOSAL TO FULLY ACQUIRE IPSOGEN
ENZOBIOCHEM SIGNS AGREEMENT WITH INCELLDX AGREE TO MARKET HPV ONCOTECT TEST
EUROFINSMEDIGENOMIX'S NEW SERVICE FOR TESTING OF DNA CONTAMINATION
NEW SOFTWARE SPEEDS VALIDATION OF AUTOMATED LIQUID HANDLING PROCESSES
ABBOTT OBTAINS CE MARK FOR ITS REAL TIME PCR TEST FOR CMV
BD DIAGNOSTICS LAUNCHES BD MAX IN THE U.S.
LABSCO SET TO DISTRIBUTE CEPHEID'S GENEXPERT? SYSTEMS
ABBOTT GETS FDA APPROVAL FOR MOLECULAR TEST FOR HEPATITIS C
AGILENT ANNOUNCES 2011 MANFRED DONIKE AWARD FOR EXCELLENCE IN SPORTS-DOPING DETECTION
ROCHE DIAGNOSTICS LAUNCHES ITS NEW BLOOD GAS ANALYZER
ROCHE DIAGNOSTICS LAUNCHES THE COBAS 8000 MODULAR ANALYZER
LIFE TECHNOLOGIES INTRODUCES 7500 FAST DX REAL-TIME PCR INSTRUMENT AND 3500 DX SERIES GENETIC ANALYZER IN JAPAN
AFFYMETRIX, FIRST IN THE INDUSTRY TO ACHIEVE FDA CLEARANCE FOR MICROARRAY-BASED GENE EXPRESSION REAGENTS
CALIPER ANNOUNCES RESEARCH COLLABORATION WITH CHI
AFFYMETRIX LAUNCHES SECOND GENERATION ONCOSCAN FFPE EXPRESS 2.0
AGILENT TECHNOLOGIES LAUNCHES AGILENT SURECYCLER 8800
INSTEM ACQUIRES BIOWISDOM
LIFE TECHNOLOGIES FORTIFIES ITS DNA SEQUENCING PLATFORM
GENSCRIPT LAUNCHES GANP TECH SERVICES GLOBALLY EXCLUDING JAPAN
ABBOTT RECEIVES CE MARK FOR NEW PCR-BASED HIV-1 TEST
QIAGEN RECEIVES SFDA APPROVAL FOR CARE HCV RT-PCR KIT V2
BD ACQUIRES ACCURI CYTOMETERS
AFFYMETRIX INTRODUCES SNP CORE REAGENT KIT FOR SNP ARRAY 6.0 CUSTOMERS
CALIPERS AND HISTORX JOINT VENTURE FOR TISSUE-BASED INTEGRATED SOLUTIONS FOR PROTEIN QUANTIFICATION OF BIOMARKERS
CYTOCELL DEVELOPS NEW FGFR1 FISH PROBE
AFFYMETRIX UNVEILS NEXT-GENERATION MICRORNA SOLUTION
INTEGENX AND CALIPER SIGN LICENSE AGREEMENT
CYTOCELL STARTS DISTRIBUTION IN BULGARIA
TAKARA BIO ESTABLISHES A SUBSIDIARY
GENE LOGIC INTRODUCES ASCENTA 4.0 WITH SUPERIOR FUNCTIONALITY
PROMEGA AND FUGENT LLC SIGN AGREEMENT FOR SUPPLY OF FUGENE 6
ABBOTT'S IBIS TECHNOLOGY TO IDENTIFY ORGANISM CAUSING PLAGUE IN AFGHANISTAN
ABBOTT PRESENTS THE PLEX-ID BIOTHREAT ASSAY
CYTOCELL LAUNCHES FIVE NEW T-CELL ALL FISH PROBES
PROMEGA LAUNCHES RELIAPREP BLOOD AND TISSUE GDNAMINIPREP SYSTEMS
LIFE TECHNOLOGIES LAUNCHES PCR DETECTION KIT FOR SALMONELLA ENTERITIDIS IN POULTRY EGGS
AFFYMETRIX LAUNCHES THE AXIOM(TM) GENOME-WIDE BOS 1 ARRAY FOR BOVINE GENOTYPING
ILLUMINA ACQUIRES EPICENTRE BIOTECHNOLOGIES
ILLUMINA AFFIRMS MISEQ(TM) PERSONAL SEQUENCING SYSTEM'S ADVANTAGES
ILLUMINA INTRODUCES NEXT GENERATION OF ISELECT(R) CUSTOM GENOTYPING PRODUCTS
BIOSPECTRUM HONORS OCIMUM BIOSOLUTIONS AS THE BEST BIOINFORMATICS COMPANY
CALIPER ACQUIRES CRI
CMB AND BIO RAD PARTNER TO DEVELOP DNA BARCODING INSTRUCTIONAL ACTIVITIES
SPARTAN RX CYP2C19 RECEIVES CE MARKING
OCIMUM CLOSES $8 MILLION TO FUEL FUTURE GROWTH
CALIPER SIGNS AGREEMENT TO ACQUIRE CRI
AGILENT AND UC DAVIS COLLABORATE FOR FOOD SAFETY RESEARCH
LIFE TECHNOLOGIES LAUNCHES APPLIED BIOSYSTEMSVETMAX-GOLD BVDV DETECTION KIT
ONLINE QUOTATION SYSTEM FOR POLYCLONAL ANTIBODY SERVICE BY GENSCRIPT
IMMUNOLOGIX TEAMS WITH GENSCRIPT
ILLUMINA INTRODUCES TRUSEQ(TM) SAMPLE PREP AND EXOME ENRICHMENT KITS
ADDITION OF GENE EDITING TECHNOLOGY
AXIOM ANALYTICAL'S ACCURATE TEMPERATURE CONTROL WITH FIBER-OPTIC
QIAGEN LAUNCHED STANDARDIZED SOLUTIONS FOR MOLECULAR ANALYSIS OF FFPE SAMPLES
ILLUMINA ANNOUNCES HISEQ 1000 SEQUENCING SYSTEM
TAKARA BIO GETS ANTI-CANCER DRUG
FDA CONSENTS ROCHE'S REAL-TIME PCR COBAS TAQMAN HCV TEST, V2.0

B. MARKET TRENDS
SPARTAN BIOSCIENCE DX-12 DNA ANALYZER - A BOON TO BIOTECHNOLOGY
REDDYMIX - A BUFFER FOR PCR REAGENTS
NEXT GENERATION PCR APPROVES EVOLUTION POLYMERASES
QUICKPROBE(TM) QPCR- A BONUS TO LIFE SCIENCES COMPANIES
MASTER CLEAR CAP STRIPS - AN ADDITION TO PCR CONSUMABLES
DIGITAL PCR TECHNOLOGY BY FLUIDIGM
GREENECHIP TECHNOLOGY- UNPREJUDICED PATHOGEN DISCOVERY
INCREASING DEMAND FOR QRT-PCR PRODUCTS
QIAGEN'S NEW SOLUTION TO ACCELERATE PCR
OPTO TECHNOLOGY'S NEW INVENTION - OTHP-0050
TIE UP BETWEEN FISHER BIOSCIENCES AND APPLIED BIOSYSTEMS
FISHER BIOSCIENCES AND DYOMICS MERGE FOR BETTERMENT
PCR MACHINES - IMPACT ON LIFE SCIENCES EQUIPMENT.

C. INDUSTRY LEADERS
ABBOTT LABORATORIES (USA)
AGILENT TECHNOLOGIES INC (USA)
BIONEER INC (USA)
COMPLETE GENOMICS, INC. (USA)
EPICENTRE BIOTECHNOLOGIES (USA)
GENISPHERE INC. (USA)
MAXIM BIOTECH, INC (USA)
OCIMUM BIOSOLUTIONS LTD.
QIAGEN INC (USA)
SACACE BIOTECHNOLOGIES S.R.L. (ITALY)
TAKARA BIO, INC.
THERMO FISHER SCIENTIFIC, INC.
LIGHTUP TECHNOLOGIES AB (SWEDEN)
HY LABORATORIES LTD. (ISRAEL)
D. POLYMERASE CHAIN REACTION (PCR) IN MEDICAL APPLICATION - A LOOK A HEAD..!!

E. KEY COMPANY PROFILES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

F. POLYMERASE CHAIN REACTION (PCR) - PATENTS
PCR PATENT EXPIRY AND ITS EFFECT ON MARKET STRATEGIES
EXPIRY OF PCR PATENT OFFERS EXCITING GROWTH OPPORTUNITIES FOR NUCLEIC ACID PURIFICATION
AND AMPLIFICATION TECHNOLOGIES
INNOVATIVE FEATURES WIDEN APPLICATION BASE AND BOOST REVENUE

PATENT EXPIRATION
MOLECULAR DIAGNOSTICS UNCHAINED
THE POLYMERASE CHAIN REACTION PATENT ENDING: AN EXPIRING PATENT MARKS THE END OF A BIOTECHNOLOGICAL ERA
EXPIRING PATENTS, UPTICK IN BIOTECH SPENDING COULD SPUR QPCR-BASED DX, TOOL DEVELOPMENT
THE POLYMERASE CHAIN REACTION PATENTS: GOING, GOING,... STILL GOING

THE POST-PATENT OPPORTUNITY
PATENT WARS
PCR - A PATENT THAT REVOLUTIONIZED BIOTECHNOLOGY AND LAUNCHED A TV SERIES
PATENT RULING COULD CUT PCR ENZYME PRICES

PCR PATENT ISSUES
1. INTRODUCTION
2. INTELLECTUAL PROPERTY RIGHTS
3. NAVIGATING THE PCR PATENT MINEFIELD
3.1. OBTAINING RIGHTS TO PRACTICE PCR
3.2. BONA-FIDE RESEARCHERS ARE NOT INFRINGERS
3.3. NOT EVERY PATENT IS A VALID PATENT

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX
A. RESEARCH FOCUS
B. ABOUT AXIS RESEARCH MIND
C. DISCLAIMER
D. FEEDBACK



LIST OF TABLES/CHARTS

I. REPORT FOCUS
1. PCR THERMOCYCLER BRANDS BY KEY PLAYERS
2. WORLDWIDE KEY PLAYERS MARKET SHARES OF Q-PCR REAGENTS - (2009-2010)

POLYMERASE CHAIN REACTION (PCR) - TECHNIQUE'S - GEOGRAPHY MARKET BRIEFING
3. PCR TECHNIQUE'S MARKET - Q-PCR, REVERSE-TRANSCRIPTION (RT) PCR, ASSEMBLY PCR, INVERSE PCR AND OTHER FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
4. PCR TECHNIQUE'S MARKET - Q-PCR, REVERSE-TRANSCRIPTION (RT) PCR, ASSEMBLY PCR, INVERSE PCR AND OTHER - % OF NORTH AMERICAN MARKET VALUE - (2010 - 2015)
5. PCR TECHNIQUE'S MARKET - Q-PCR, REVERSE-TRANSCRIPTION (RT) PCR, ASSEMBLY PCR, INVERSE PCR AND OTHER FOR EUROPE - (2009-2015, IN USD$ MILLION)
6. PCR TECHNIQUE'S MARKET - Q-PCR, REVERSE-TRANSCRIPTION (RT) PCR, ASSEMBLY PCR, INVERSE PCR AND OTHER - % OF EUROPEAN MARKET VALUE - (2010 - 2015)
7. PCR TECHNIQUE'S MARKET - Q-PCR, REVERSE-TRANSCRIPTION (RT) PCR, ASSEMBLY PCR, INVERSE PCR AND OTHER FOR ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
8. PCR TECHNIQUE'S MARKET - Q-PCR, REVERSE-TRANSCRIPTION (RT) PCR, ASSEMBLY PCR, INVERSE PCR AND OTHER - % OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
9. PCR TECHNIQUE'S MARKET - Q-PCR, REVERSE-TRANSCRIPTION (RT) PCR, ASSEMBLY PCR, INVERSE PCR AND OTHER FOR LATIN AMERICA - (2009-2015, IN USD$ MILLION)
10. PCR TECHNIQUE'S MARKET - Q-PCR, REVERSE-TRANSCRIPTION (RT) PCR, ASSEMBLY PCR, INVERSE PCR AND OTHER - % OF LATIN AMERICAN MARKET VALUE - (2010 - 2015)
11. PCR TECHNIQUE'S MARKET - Q-PCR, REVERSE-TRANSCRIPTION (RT) PCR, ASSEMBLY PCR, INVERSE PCR AND OTHER FOR REST OF WORLD - (2009-2015, IN USD$ MILLION)
12. PCR TECHNIQUE'S MARKET - Q-PCR, REVERSE-TRANSCRIPTION (RT) PCR, ASSEMBLY PCR, INVERSE PCR AND OTHER - % OF REST OF WORLD MARKET VALUE - (2010 - 2015)

POLYMERASE CHAIN REACTION (PCR) - PRODUCT/TOOLS - GEOGRAPHY MARKET BRIEFING
13. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
14. PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF NORTH AMERICAN MARKET VALUE - (2010 - 2015)
15. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR EUROPE - (2009-2015, IN USD$ MILLION)
16. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF EUROPEAN MARKET VALUE - (2010 - 2015)
17. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
18. PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
19. PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR LATIN AMERICA - (2009-2015, IN USD$ MILLION)
20. PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF LATIN AMERICAN MARKET VALUE - (2010 - 2015)
21. PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR REST OF WORLD - (2009-2015, IN USD$ MILLION)
22. PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF REST OF WORLD MARKET VALUE - (2010 - 2015)

POLYMERASE CHAIN REACTION (PCR) - END-USERS APPLICATION - GEOGRAPHY MARKET BRIEFING
23. APPLICATION MARKET - RESEARCH, DIAGNOSIS, INFECTIOUS DISEASES, FORENSIC SCIENCES AND OTHER FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
24. APPLICATION MARKET - RESEARCH, DIAGNOSIS, INFECTIOUS DISEASES, FORENSIC SCIENCES AND OTHER - % OF NORTH AMERICAN MARKET VALUE - (2010 - 2015)
25. APPLICATION MARKET - RESEARCH, DIAGNOSIS, INFECTIOUS DISEASES, FORENSIC SCIENCES AND OTHER FOR EUROPE - (2009-2015, IN USD$ MILLION)
26. APPLICATION MARKET - RESEARCH, DIAGNOSIS, INFECTIOUS DISEASES, FORENSIC SCIENCES AND OTHER - % OF EUROPEAN MARKET VALUE - (2010 - 2015)
27. APPLICATION MARKET - RESEARCH, DIAGNOSIS, INFECTIOUS DISEASES, FORENSIC SCIENCES AND OTHER FOR ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
28. APPLICATION MARKET - RESEARCH, DIAGNOSIS, INFECTIOUS DISEASES, FORENSIC SCIENCES AND OTHER - % OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
29. APPLICATION MARKET - RESEARCH, DIAGNOSIS, INFECTIOUS DISEASES, FORENSIC SCIENCES AND OTHER FOR LATIN AMERICA - (2009-2015, IN USD$ MILLION)
30. APPLICATION MARKET - RESEARCH, DIAGNOSIS, INFECTIOUS DISEASES, FORENSIC SCIENCES AND OTHER - % OF LATIN AMERICAN MARKET VALUE - (2010 - 2015)
31. APPLICATION MARKET - RESEARCH, DIAGNOSIS, INFECTIOUS DISEASES, FORENSIC SCIENCES AND OTHER FOR REST OF WORLD - (2009-2015, IN USD$ MILLION)
32. APPLICATION MARKET - RESEARCH, DIAGNOSIS, INFECTIOUS DISEASES, FORENSIC SCIENCES AND OTHER - % OF REST OF WORLD MARKET VALUE - (2010 - 2015)

POLYMERASE CHAIN REACTION (PCR) - BY END-USERS APPLICATION - RESEARCH APPLICATION
33. PCR RESEARCH APPLICATION MARKET - DNA SEQUENCING, DNA CLONING, GENE EXPRESSION AND OTHER FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
34. PCR RESEARCH APPLICATION MARKET - DNA SEQUENCING, DNA CLONING, GENE EXPRESSION AND OTHER - % OF NORTH AMERICAN MARKET VALUE - (2010 - 2015)
35. PCR RESEARCH APPLICATION MARKET - DNA SEQUENCING, DNA CLONING, GENE EXPRESSION AND OTHER FOR EUROPE - (2009-2015, IN USD$ MILLION)
36. PCR RESEARCH APPLICATION MARKET - DNA SEQUENCING, DNA CLONING, GENE EXPRESSION AND OTHER - % OF EUROPEAN MARKET VALUE - (2010 - 2015)
37. PCR RESEARCH APPLICATION MARKET - DNA SEQUENCING, DNA CLONING, GENE EXPRESSION AND OTHER FOR ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
38. PCR RESEARCH APPLICATION MARKET - DNA SEQUENCING, DNA CLONING, GENE EXPRESSION AND OTHER - % OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
39. PCR RESEARCH APPLICATION MARKET - DNA SEQUENCING, DNA CLONING, GENE EXPRESSION AND OTHER FOR LATIN AMERICA - (2009-2015, IN USD$ MILLION)
40. PCR RESEARCH APPLICATION MARKET - DNA SEQUENCING, DNA CLONING, GENE EXPRESSION AND OTHER - % OF LATIN AMERICAN MARKET VALUE - (2010 - 2015)
41. PCR RESEARCH APPLICATION MARKET - DNA SEQUENCING, DNA CLONING, GENE EXPRESSION AND OTHER FOR REST OF WORLD - (2009-2015, IN USD$ MILLION)
42. PCR RESEARCH APPLICATION MARKET - DNA SEQUENCING, DNA CLONING, GENE EXPRESSION AND OTHER - % OF REST OF WORLD MARKET VALUE - (2010 - 2015)

POLYMERASE CHAIN REACTION (PCR) - BY END-USERS APPLICATION - DIAGNOSIS APPLICATION
43. PCR DIAGNOSIS APPLICATION MARKET - CANCER, GENETIC ABNORMALITIES, TISSUE TYPING AND OTHER FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
44. PCR DIAGNOSIS APPLICATION MARKET - CANCER, GENETIC ABNORMALITIES, TISSUE TYPING AND OTHER - % OF NORTH AMERICAN MARKET VALUE - (2010 - 2015)
45. PCR DIAGNOSIS APPLICATION MARKET - CANCER, GENETIC ABNORMALITIES, TISSUE TYPING AND OTHER FOR EUROPE - (2009-2015, IN USD$ MILLION)
46. PCR DIAGNOSIS APPLICATION MARKET - CANCER, GENETIC ABNORMALITIES, TISSUE TYPING AND OTHER - % OF EUROPEAN MARKET VALUE - (2010 - 2015)
47. PCR DIAGNOSIS APPLICATION MARKET - CANCER, GENETIC ABNORMALITIES, TISSUE TYPING AND OTHER FOR ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
48. PCR DIAGNOSIS APPLICATION MARKET - CANCER, GENETIC ABNORMALITIES, TISSUE TYPING AND OTHER - % OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
49. PCR DIAGNOSIS APPLICATION MARKET - CANCER, GENETIC ABNORMALITIES, TISSUE TYPING AND OTHER FOR LATIN AMERICA - (2009-2015, IN USD$ MILLION)
50. PCR DIAGNOSIS APPLICATION MARKET - CANCER, GENETIC ABNORMALITIES, TISSUE TYPING AND OTHER - % OF LATIN AMERICAN MARKET VALUE - (2010 - 2015)
51. PCR DIAGNOSIS APPLICATION MARKET - CANCER, G

Looking for something else?